Digital Health – What Will Stay & What will Get Left Behind?

What Will Stay & What Will Get Left Behind?

OurCrowd’s senior professionals and digital health portfolio presents what will remain two years from today after the rapid acceleration of digital health technologies we’ve experienced through COVID-19.

Alon Roitman, Business Development Analyst, OurCrowd
Laly David, Partner and Head of Business Development, OurCrowd
Dan Fishel, VP Business Development, OurCrowd
Yossi Bahagon, Managing Partner, Qure
Eyal Baum, Director of Strategic Accounts, TytoCare
David Harel, CEO, CytoREason
Omri Shor, CEO, Medisafe

July 9, 2020

For more information and to invest